Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

Sponsor
Alliance for Clinical Trials in Oncology (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT01511562
Collaborator
National Cancer Institute (NCI) (NIH)
113
126
2
0.9

Study Details

Study Description

Brief Summary

The purpose of this study is to find out what effects (good and/or bad) treatment with chemotherapy and stem cell transplant compared with chemotherapy alone will have on primary CNS B-cell lymphoma. Currently the best treatment for patients with primary CNS B-cell lymphoma is not known.

Condition or Disease Intervention/Treatment Phase
Phase 2

Detailed Description

Primary Objective:

To compare the two-year progression-free survival (PFS) of patients treated with the myeloablative consolidation treatment strategy of HDT/ASCT versus those treated with non-myeloablative consolidation chemotherapy with cytarabine and etoposide

Secondary Objectives:
  1. To compare the two-year event-free survival (EFS) of patients treated with consolidation HDT/ASCT versus those treated with consolidation chemotherapy consisting of etoposide and cytarabine

  2. To compare the overall survival (OS) of patients treated with the consolidation HDT/ASCT versus those treated with consolidation chemotherapy consisting of etoposide and cytarabine

  3. To assess the toxicities associated with consolidation HDT/ASCT versus consolidation consisting of etoposide and cytarabine

  4. To determine diffusion MRI metrics (ADCmini, ADC25%, and ADCmean) prior to induction chemotherapy, after one full induction chemotherapy cycle, and at the end of induction chemotherapy as a predictor of response and outcome (CALGB 581101)

  5. To determine brain FDG-PET metrics (tumor SUV and tumor versus background SUV) prior to induction chemotherapy, after one full induction chemotherapy cycle, and at the end of induction chemotherapy as a predictor of response and outcome (CALGB 581101)

  6. To determine whether low baseline ADC measurements are associated with shorter PFS and OS (CALGB 581101)

  7. To determine whether reduction in tumor SUV by > 25% on brain FDG-PET/CT after one cycle of induction therapy is associated with improved PFS and OS (CALGB 581101)

  8. To determine which IHC-based biomarkers are predictive of an adverse prognosis (CALGB

  1. To determine which IHC-based biomarkers are predictive of a favorable prognosis (CALGB
  1. for BCL6 (B-cell CLL/lymphoma 6), and STAT 6 (signal transducer and activator of transcription 6, interleukin-4 induced)
  1. To analyze tumor tissue for gene expression profiles, and to correlate these profiles with treatment outcomes (CALGB 151113)

  2. To determine whether CSF proteome is a predictor of outcomes (prognostic marker) irrespective of treatment arm (CALGB 151113) for (IL-10 (interleukin 10) and C3 (complement component 3)

  3. To assess the neurocognitive function of patients treated with consolidation HDT/ASCT versus those treated with consolidation chemotherapy (etoposide and cytarabine) as measured by serial administration of the International PCNSL Collaborative Group (IPCG) neurocognitive battery and evaluate the long-term survivorship differences between the two arms (CALGB 71105)

Study Design

Study Type:
Interventional
Actual Enrollment :
113 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma
Study Start Date :
Sep 1, 2012
Anticipated Primary Completion Date :
Oct 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Other: Arm I

Patients undergo induction therapy for five cycles as defined in the protocol. Patients undergo stem cell transplant.

Drug: carmustine
Given IV

Drug: thiotepa
Given IV

Procedure: stem cell transplant

Drug: G-CSF

Other: Arm II

Patients undergo induction therapy for five cycles as defined in the protocol. Patients undergo consolidation chemotherapy.

Drug: cytarabine
Given IV

Drug: etoposide
Given IV

Drug: G-CSF

Outcome Measures

Primary Outcome Measures

  1. progression free survival [Up to 10 years]

Secondary Outcome Measures

  1. event free survival [Up to 10 years]

  2. number of participants with treatment-related adverse events as assessed by CTCAE v4.0 [Up to 10 years]

  3. overall survival [Up to 10 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
  1. Documentation of Disease: Diagnosis of primary CNS diffuse large B-cell lymphoma confirmed by one of the following: brain biopsy or resection, cerebrospinal fluid and vitreous fluid.

  2. Other Lymphomas: Patients must have no evidence or history of non-Hodgkin lymphoma (NHL) outside of CNS.

  3. Previous Treatment: Patients must have no prior chemotherapy or radiation therapy for lymphoma.

  4. Age- Patients must be between the ages of 18 and 75 years.

  5. Karnofsky Performance Scale - Patients must measure Karnofsky Performance Scale ≥ 30 (≥ 50 for patients ages 60-70).

  6. Pregnancy and Nursing Status - Patients must be non-pregnant and non-nursing; women of childbearing potential must have a negative serum or urine pregnancy test 10-14 days prior to registration; in addition, women and men of childbearing potential must commit to use an effective form of contraception throughout their participation in this study; appropriate methods of birth control include abstinence, oral contraceptives, implantable hormonal contraceptives, or double barrier method (diaphragm plus condom)

  7. HIV - Patients must have negative HIV serology.

  8. Hepatitis - Patients must have negative HCV serology (unless HBsAb positive patient has recently received HBV vaccine, in this case HBcAb should be negative). All patients must be screened for hepatitis B infection before starting treatment. Those patients who test positive for hepatitis B should be closely monitored for evidence of active HBV infection and hepatitis during and for several months after rituximab treatment. PCNSL patients with a history of hepatitis B infection should be treated with entecavir or lamivudine (physician discretion for choice of drug) as antiviral prophylaxis to prevent hepatitis B reactivation.

  9. Organ Transplant or Immunosuppressant Therapy - Patient must have no history of organ transplantation or ongoing immunosuppressant therapy.

  10. Required Initial Laboratory Values: ANC ≥ 1500/mcL, AST and ALT < 2 x upper limit of normal (ULN), total bilirubin ≤ 3 mg/dL, creatinine clearance ≥ 50 mL/min, platelet count ≥ 100,000/mcL

Contacts and Locations

Locations

Site City State Country Postal Code
1 Anchorage Associates in Radiation Medicine Anchorage Alaska United States 98508
2 Anchorage Radiation Therapy Center Anchorage Alaska United States 99504
3 Alaska Breast Care and Surgery LLC Anchorage Alaska United States 99508
4 Alaska Oncology and Hematology LLC Anchorage Alaska United States 99508
5 Alaska Women's Cancer Care Anchorage Alaska United States 99508
6 Anchorage Oncology Centre Anchorage Alaska United States 99508
7 Katmai Oncology Group Anchorage Alaska United States 99508
8 Providence Alaska Medical Center Anchorage Alaska United States 99508
9 Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank California United States 91505
10 UC San Diego Moores Cancer Center La Jolla California United States 92093
11 University of California Davis Comprehensive Cancer Center Sacramento California United States 95817
12 UCSF Medical Center-Mount Zion San Francisco California United States 94115
13 UCSF Medical Center-Parnassus San Francisco California United States 94143
14 Yale University New Haven Connecticut United States 06520
15 Moffitt Cancer Center Tampa Florida United States 33612
16 Emory University/Winship Cancer Institute Atlanta Georgia United States 30322
17 Saint Luke's Mountain States Tumor Institute Boise Idaho United States 83712
18 Saint Luke's Mountain States Tumor Institute - Fruitland Fruitland Idaho United States 83619
19 Saint Luke's Mountain States Tumor Institute - Meridian Meridian Idaho United States 83642
20 Saint Luke's Mountain States Tumor Institute - Nampa Nampa Idaho United States 83686
21 Saint Luke's Mountain States Tumor Institute-Twin Falls Twin Falls Idaho United States 83301
22 University of Illinois Chicago Illinois United States 60612
23 University of Chicago Comprehensive Cancer Center Chicago Illinois United States 60637
24 Reid Health Richmond Indiana United States 47374
25 University of Kansas Cancer Center Kansas City Kansas United States 66160
26 Oncology Hematology Care Inc-Crestview Crestview Hills Kentucky United States 41017
27 Tulane University Health Sciences Center New Orleans Louisiana United States 70112
28 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland United States 21287
29 Massachusetts General Hospital Cancer Center Boston Massachusetts United States 02114
30 Brigham and Women's Hospital Boston Massachusetts United States 02115
31 Dana-Farber Cancer Institute Boston Massachusetts United States 02215
32 Bronson Battle Creek Battle Creek Michigan United States 49017
33 Mercy Health Saint Mary's Grand Rapids Michigan United States 49503
34 Spectrum Health at Butterworth Campus Grand Rapids Michigan United States 49503
35 Borgess Medical Center Kalamazoo Michigan United States 49001
36 Bronson Methodist Hospital Kalamazoo Michigan United States 49007
37 West Michigan Cancer Center Kalamazoo Michigan United States 49007
38 Mercy Health Mercy Campus Muskegon Michigan United States 49444
39 Lakeland Community Hospital Niles Michigan United States 49120
40 Spectrum Health Reed City Hospital Reed City Michigan United States 49677
41 Lakeland Hospital Saint Joseph Michigan United States 49085
42 Marie Yeager Cancer Center Saint Joseph Michigan United States 49085
43 Munson Medical Center Traverse City Michigan United States 49684
44 Metro Health Hospital Wyoming Michigan United States 49519
45 Mayo Clinic Rochester Minnesota United States 55905
46 Washington University School of Medicine Saint Louis Missouri United States 63110
47 University of Nebraska Medical Center Omaha Nebraska United States 68198
48 Weill Medical College of Cornell University New York New York United States 10065
49 University of Rochester Rochester New York United States 14642
50 Stony Brook University Medical Center Stony Brook New York United States 11794
51 State University of New York Upstate Medical University Syracuse New York United States 13210
52 Duke University Medical Center Durham North Carolina United States 27710
53 Dayton Physicians LLC-Miami Valley South Centerville Ohio United States 45459
54 Oncology Hematology Care Inc-Eden Park Cincinnati Ohio United States 45202
55 Oncology Hematology Care Inc-Mercy West Cincinnati Ohio United States 45211
56 Oncology Hematology Care Inc - Anderson Cincinnati Ohio United States 45230
57 Oncology Hematology Care Inc-Kenwood Cincinnati Ohio United States 45236
58 Oncology Hematology Care Inc-Blue Ash Cincinnati Ohio United States 45242
59 Good Samaritan Hospital - Dayton Dayton Ohio United States 45406
60 Miami Valley Hospital Dayton Ohio United States 45409
61 Dayton Physicians LLC-Samaritan North Dayton Ohio United States 45415
62 Samaritan North Health Center Dayton Ohio United States 45415
63 Dayton NCI Community Oncology Research Program Dayton Ohio United States 45420
64 Oncology Hematology Care Inc-Healthplex Fairfield Ohio United States 45014
65 Armes Family Cancer Center Findlay Ohio United States 45840
66 Blanchard Valley Hospital Findlay Ohio United States 45840
67 Orion Cancer Care Findlay Ohio United States 45840
68 Atrium Medical Center-Middletown Regional Hospital Franklin Ohio United States 45005-1066
69 Dayton Physicians LLC-Atrium Franklin Ohio United States 45005
70 Dayton Physicians LLC-Wayne Greenville Ohio United States 45331
71 Wayne Hospital Greenville Ohio United States 45331
72 Greater Dayton Cancer Center Kettering Ohio United States 45409
73 Kettering Medical Center Kettering Ohio United States 45429
74 Dayton Physicians LLC-Signal Point Middletown Ohio United States 45042
75 Dayton Physicians LLC-Wilson Sidney Ohio United States 45365
76 Springfield Regional Cancer Center Springfield Ohio United States 45504
77 Springfield Regional Medical Center Springfield Ohio United States 45505
78 Dayton Physicians LLC-Upper Valley Troy Ohio United States 45373
79 Upper Valley Medical Center Troy Ohio United States 45373
80 Surgical Associates Inc Tulsa Oklahoma United States 74136
81 Warren Clinic Oncology-Tulsa Tulsa Oklahoma United States 74146
82 Saint Charles Health System Bend Oregon United States 97701
83 Clackamas Radiation Oncology Center Clackamas Oregon United States 97015
84 Providence Oncology and Hematology Care Southeast Clackamas Oregon United States 97015
85 Bay Area Hospital Coos Bay Oregon United States 97420
86 Providence Milwaukie Hospital Milwaukie Oregon United States 97222
87 Providence Newberg Medical Center Newberg Oregon United States 97132
88 Providence Willamette Falls Medical Center Oregon City Oregon United States 97045
89 Providence Portland Medical Center Portland Oregon United States 97213
90 Providence Saint Vincent Medical Center Portland Oregon United States 97225
91 Geisinger Medical Center Danville Pennsylvania United States 17822
92 Lewistown Hospital Lewistown Pennsylvania United States 17044
93 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania United States 15232
94 Huntsman Cancer Institute/University of Utah Salt Lake City Utah United States 84112
95 Central Vermont Medical Center/National Life Cancer Treatment Berlin Vermont United States 05602
96 University of Vermont Medical Center Burlington Vermont United States 05401
97 University of Vermont College of Medicine Burlington Vermont United States 05405
98 Virginia Commonwealth University/Massey Cancer Center Richmond Virginia United States 23298
99 Providence Regional Cancer System-Aberdeen Aberdeen Washington United States 98520
100 Cancer Care Center at Island Hospital Anacortes Washington United States 98221
101 Swedish Cancer Institute-Eastside Oncology Hematology Bellevue Washington United States 98005
102 PeaceHealth Saint Joseph Medical Center Bellingham Washington United States 98225
103 Providence Regional Cancer System-Centralia Centralia Washington United States 98531
104 Swedish Medical Center-Edmonds Edmonds Washington United States 98026
105 Providence Regional Cancer Partnership Everett Washington United States 98201
106 Swedish Cancer Institute-Issaquah Issaquah Washington United States 98029
107 Providence Regional Cancer System-Lacey Lacey Washington United States 98503
108 PeaceHealth Saint John Medical Center Longview Washington United States 98632
109 Minor and James Medical PLLC Seattle Washington United States 98104
110 Pacific Gynecology Specialists Seattle Washington United States 98104
111 Swedish Medical Center-Ballard Campus Seattle Washington United States 98107
112 Fred Hutchinson Cancer Research Center Seattle Washington United States 98109
113 Seattle Cancer Care Alliance Seattle Washington United States 98109
114 Group Health Cooperative-Seattle Seattle Washington United States 98112
115 Swedish Medical Center-First Hill Seattle Washington United States 98122-4307
116 University of Washington Medical Center Seattle Washington United States 98195
117 Providence Regional Cancer System-Shelton Shelton Washington United States 98584
118 Rockwood Clinic Cancer Treatment Center-Valley Spokane Valley Washington United States 99216
119 Rockwood Cancer Treatment Center-DHEC-Downtown Spokane Washington United States 99204
120 PeaceHealth Southwest Medical Center Vancouver Washington United States 98664
121 Compass Oncology Vancouver Vancouver Washington United States 98684
122 Providence Saint Mary Regional Cancer Center Walla Walla Washington United States 99362
123 North Star Lodge Cancer Center at Yakima Valley Memorial Hospital Yakima Washington United States 98902
124 Providence Regional Cancer System-Yelm Yelm Washington United States 98597
125 Mayo Clinic Health System-Franciscan Healthcare La Crosse Wisconsin United States 54601
126 University of Wisconsin Hospital and Clinics Madison Wisconsin United States 53792

Sponsors and Collaborators

  • Alliance for Clinical Trials in Oncology
  • National Cancer Institute (NCI)

Investigators

  • Study Chair: Tracy Batchelor, MD, MPH, Massachusetts General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alliance for Clinical Trials in Oncology
ClinicalTrials.gov Identifier:
NCT01511562
Other Study ID Numbers:
  • CALGB-51101
  • CALGB-51101
  • CDR0000721927
  • NCI-2012-00110
First Posted:
Jan 18, 2012
Last Update Posted:
Aug 17, 2021
Last Verified:
Aug 1, 2021

Study Results

No Results Posted as of Aug 17, 2021